Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...
Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...
After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...
SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.
Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...
In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.
Cardiovascular disease is a general term that refers to many different types of heart problems.Heart disease is the ...
In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results